Gene gun or a biolistic particle delivery system, is an instrument used for transporting exogenous DNA or foreign DNA (transgenes) into the cells. Gene guns can transform the target tissues of animals or plants physically by injecting or delivering the genetic information. Gene gun technology includes carrying of a RNA or DNA, typically a plasmid DNA, coated over a transporter, i.e. an elemental particle of heavy metal such as microscopic titanium or gold particles, often known as bullets into living tissues. The technique is often referred to as biolistic. The biolistic particle delivery system or gene gun is able to transform not just nucleus, but nearly any type of cell, including organelles along with plastids and plants. The technique involves high velocity acceleration of particles to perforate the cell membrane and transport the desired materials into living cells of tissues. The acceleration needed is provided by electric discharge, centripetal force, firing explosives, or compressed gas. Due to this reason, the technique is also known as particle acceleration, microprojectile bombardment, and particle bombardment. This technique was developed in the early 1980s and revolutionized genetic engineering that involves altering the genes of an organism, i.e. transformation. Transformation is a process of manipulating the genetic makeup of a cell by incorporating a foreign or non-self-genetic material into it. This transforms the genetic makeup of the transformed organism. For example, plants can be incorporated with pest resistance or drought resistance genes.
The global gene gun market is expected to grow substantially due to the rise in recombinant DNA technology and genetic engineering. Increasing interest of scientists and researchers in this field and its varied application will drive the gene gun market as it plays a significant role in transformation experiments. Furthermore, advancements in agriculture, inclination toward genetically modified crops, and increasing research and development in the life science sector will fuel market growth. Rapid technological advancements in gene gun technology is anticipated to propel market growth during the forecast period. However, lack of sustained gene expression in target cell, death of the target tissue, and inaccuracy in the method may hamper the growth of the market. Also, altering with genetic makeup involves some ethical issues. These factors collectively may restrain the growth of the market in the near future.
The global gene gun market can be segmented on the basis of modality, applications, and geographical region. Gene guns are segmented on the basis of modality into portable handheld type, desktop type and others. With increasing recombinant DNA technology and genetic engineering, gene guns are finding extensive applications in agriculture, medical and other sectors. In agriculture, crops are genetically modified to improve their quality, nutritious value, reduce maturation time, develop resistance to pests, diseases, and herbicides, and to increase tolerance to harsh environmental conditions like extreme temperatures. In the medical field, gene gun technology has been used in vaccination as DNA vaccination and in other therapeutic applications.
Geographically, the gene gun market can be segmented into five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the gene gun market globally. This major share of the region is attributed to technological advancement and high quality research and development in genetic engineering which enables greater usage of the instrument. Asia Pacific is expected to be the rapidly growing market due to increasing research in genetic engineering and recombinant DNA technology and government funding supporting research in this field. Therefore, Asia Pacific and Latin America are lucrative target areas for major players of the gene gun market.
Key players in the gene gun market are Chintek Technology Co., Ltd, Bio-Rad Laboratories, Inc., Wealtec Corp., DuPont, Harvard Bioscience, Inc. (BTX), Thermo Fisher Scientific Inc. (Life Technologies Corporation), Ningbo Scientz Biotechnology Co., Ltd, and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.